ADPT News and Press, Adaptive Biotechnologies Corporation From 10/13/25

2025-10-13 05:25:10 ET More on ARK Invest ARK Innovation ETF: Time To Go All In ARKW: Curb Your Enthusiasm, This ETF Is Up 100% But Not That Unique ARKK: Trading Into The Wind Cathie Wood's Ark Invest weekly recap: adds more Alibaba, Baidu, Kodiak AI, Intelli...

2025-10-06 13:29:43 ET Introduction My last look at Adaptive Biotechnologies ( ADPT ) was in September 2024. The company was amid a post-pandemic transition. As revenues from its Immune Medicine ((IM)) segment, which included a COVID test product, were declining, Adaptive's ...

2025-09-30 07:53:42 ET from Guggenheim issued a price target of $20.00 for ADPT on 2025-09-30 10:43:02. The adjusted price target was set to $20.00. At the time of the announcement, ADPT was trading at $13.46. The overall price target consensus is at $12.33 with high pri...

2025-09-10 15:58:04 ET Adaptive Biotechnologies Corporation (ADPT) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 1:05 PM EDT... Read the full article on Seeking Alpha For further details see: Adaptive Biotechnologies Corporation (ADPT) Presents A...

2025-08-28 10:20:00 ET The future of healthcare is being forged at the intersection of biology and technology. Much like software and data analytics reshaped industries like finance and retail, a similar transformation is now creating a new landscape for investors in medicine. Genomics ...

SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating...

2025-08-08 06:05:00 ET The following segment was excerpted from the Aristotle Focus Growth Q2 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Aristotle Focus Growth Q2 Highlights: Top Performers, Surprises...

2025-08-06 19:01:00 ET Just after market close, Adaptive Biotechnologies (NASDAQ: ADPT) took the wraps off its second quarter. The following day, investors reacted to this by bidding the biotech company's stock up by almost 6%. That was far higher than the 0.7% lift of the S&a...

2025-08-06 02:14:06 ET More on Adaptive Biotechnologies Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call Transcript Adaptive Biotechnologies GAAP EPS of -$0.17 beats by $0.07, revenue of $58.88M beats by $9.48M Seeking Alpha’s Quant Rating on ...

2025-08-06 02:13:34 ET Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Conference Call August 05, 2025, 04:30 PM ET Company Participants Chad M. Robins - Co-Founder, CEO & Chairman Karina Calzadilla - Vice President of Investor Relations Kyle Pis...